Close
  Indian J Med Microbiol
 

Figure 21: Contrast-enhanced magnetic resonance performed for the patient, a known case of visceral larva migrans, with a repeat follow-up sonogram after 2 years. (a) Coronal section of the liver in portal venous phase of contrast-enhanced magnetic resonance imaging for upper abdomen performed before initiation of antihelminthic drugs reveals a conglomerated hypointense, ring enhancing lesion in the right lobe of liver, segments VI and VII (bold white arrow outlined with black). (b) Axial section of the liver in portal venous phase of contrast-enhanced magnetic resonance imaging for upper abdomen performed before initiation of antihelminthic drugs reveals a conglomerated hypointense, ring enhancing lesion in the right lobe of liver, segments VI and VII (bold white arrow outlined with black). (c) The lesions are visualized after therapy in the posterior segment (bold white arrow) as compared to Figure 21a and b and appear smaller in size

Figure 21: Contrast-enhanced magnetic resonance performed for the patient, a known case of visceral larva migrans, with a repeat follow-up sonogram after 2 years. (a) Coronal section of the liver in portal venous phase of contrast-enhanced magnetic resonance imaging for upper abdomen performed before initiation of antihelminthic drugs reveals a conglomerated hypointense, ring enhancing lesion in the right lobe of liver, segments VI and VII (bold white arrow outlined with black). (b) Axial section of the liver in portal venous phase of contrast-enhanced magnetic resonance imaging for upper abdomen performed before initiation of antihelminthic drugs reveals a conglomerated hypointense, ring enhancing lesion in the right lobe of liver, segments VI and VII (bold white arrow outlined with black). (c) The lesions are visualized after therapy in the posterior segment (bold white arrow) as compared to Figure 21a and b and appear smaller in size